Literature DB >> 9572028

Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program.

S A Marshall1, W W Wilke, M A Pfaller, R N Jones.   

Abstract

Staphylococci are major causes of nosocomial blood stream infection. The recently completed SCOPE Surveillance Program found that coagulase-negative staphylococci (CoNS) and Staphylococcus aureus were the first and second most common etiologic agents, respectively, causing nosocomial blood stream infection in the USA. The frequency of oxacillin resistance was 68% among 1553 strains of CoNS and 26% among 787 strains of S. aureus in this study. Extended susceptibility profiles were generated for a subset of 150 S. aureus and 300 CoNS against 16 antimicrobial agents. Oxacillin-susceptible strains of both CoNS and S. aureus were uniformly susceptible to beta-lactam agents with the exception of ampicillin and penicillin. Oxacillin-susceptible S. aureus were also highly susceptible to the fluoroquinolones, aminoglycosides, and trimethoprim/sulfamethoxazole. The oxacillin-susceptible CoNS were less susceptible to these agents, and only glycopeptides were reliably active against oxacillin-resistant strains. PCR detection of the mecA gene was used to scrutinize current NCCLS interpretive breakpoint MICs for determining susceptibility or resistance to oxacillin. We found complete concordance between the presence or absence of mecA and the NCCLS oxacillin interpretive breakpoint categories for S. aureus. In contrast, the NCCLS breakpoints for oxacillin significantly underestimate the degree of true oxacillin resistance among CoNS. Using the presence of mecA as the reference standard, we detected 15.7% false susceptibility to oxacillin using a MIC susceptible breakpoint concentration of < or = 2 micrograms/mL. Lowering the oxacillin MIC breakpoint to < or = 0.25 microgram/mL for CoNS would greatly improve the accuracy of the MIC test performance. We found that both the current oxacillin disk test and the 30-microgram ceftizoxime disk test functioned quite well in predicting those strains of CoNS that contain mecA. These studies have demonstrated both a high level of antimicrobial resistance among nosocomial blood stream isolates of staphylococci as well as significant problems with the current NCCLS breakpoints for oxacillin when testing CoNS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572028     DOI: 10.1016/s0732-8893(97)00212-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  40 in total

1.  Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study.

Authors:  F C Tenover; R N Jones; J M Swenson; B Zimmer; S McAllister; J H Jorgensen
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Ability of the modified Vitek card to detect coagulase-negative staphylococcal with mecA and Oxacillin-resistant phenotypes.

Authors:  S A Marshall; M A Pfaller; R N Jones
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Role of global surveillance in combating bacterial resistance.

Authors:  A Marchese; G C Schito
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci.

Authors:  Z Hussain; L Stoakes; V Massey; D Diagre; V Fitzgerald; S El Sayed; R Lannigan
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test.

Authors:  Z Hussain; L Stoakes; S Garrow; S Longo; V Fitzgerald; R Lannigan
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci.

Authors:  T Yamazumi; I Furuta; D J Diekema; M A Pfaller; R N Jones
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Evaluation of the Vitek card GPS105 and VTK-RO7.01 software for detection of oxacillin resistance in clinically relevant coagulase-negative staphylococci.

Authors:  F Martinez; L J Chandler; B S Reisner; G L Woods
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

8.  Detection of methicillin resistance in primary blood culture isolates of coagulase-negative staphylococci by PCR, slide agglutination, disk diffusion, and a commercial method.

Authors:  Zafar Hussain; Luba Stoakes; Michael A John; Shaunalee Garrow; Viivi Fitzgerald
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

9.  In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci.

Authors:  Peter A Smith; Michael E Powers; Tucker C Roberts; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

10.  Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.

Authors:  M Carugati; C A Petti; C Arnold; J M Miro; J M Pericàs; C Garcia de la Maria; Z Kanafani; E Durante-Mangoni; J Baddley; D Wray; J L Klein; F Delahaye; N Fernandez-Hidalgo; M M Hannan; D Murdoch; A Bayer; V H Chu
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.